107 algorithm-development-"Multiple"-"Prof"-"Prof" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
to reveal cells, genes, proteins and pathways underlying the infection process, parasite development and interaction with the hosts. These findings are further validated by in situ localization of gene
-
to the University. This full-time post is initially fixed-term for 12 months with possible extension for a further 12 months. The Podium Institute constitutes a world-unique ecosystem within which to develop and
-
learning and computational methods. In addition, candidates should provide evidence of creative and critical thinking as applied to the development and execution of a cohesive programme of research. A
-
an interdisciplinary team. Experience in software development and application to automated instruments or robotics would be advantageous. Informal enquiries may be addressed to Harrison Steel (email: harrison.steel
-
an ambitious, motivated, and hard-working Postdoctoral Research Associate to join Dr Antoni Wrobel’s lab. Our small research team investigates molecular mechanisms underlying viral evolution and host changes
-
challenges, from reducing our carbon emissions to developing vaccines during a pandemic. The Department of Psychiatry is based on the Warneford Hospital site in Oxford – a friendly, welcoming place of work
-
. The scale of these assays will be large, and this post will require excellent organization and planning skills. Previous experience with qPCR , flow cytometry and experimental evolution would also be
-
learning, at the intersection of reinforcement learning, deep learning and computer vision, in order to train effective robotic agents in simulation. You should hold a relevant PhD/DPhil (or near completion
-
advanced functional genomics, transcriptomics, and proteomics approaches, you will develop novel therapeutic strategies for cancer immunotherapy. You will be responsible for managing your own academic
-
relevant assays to interrogate dysregulation induced in iPS-neurons by exposure to material from Alzheimer’s brains. You will develop an iPS-neuronal-microglial co-culture screening platform that can assess